Avai Bio, Inc. (f/k/a Avant Technologies Inc. and Trend Innovations Holding Inc.) is a technology company specializing in acquiring, creating, and developing innovative and advanced technologies utilizing artificial intelligence (AI) as well as providing a host of information technology consulting services. The Company considers itself a native expert in the field of information technology base…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$2M
▼ -53.2% YoY
Op. Margin
–
ROIC
-3215.52%
▼ -296.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$1M
▲ +13.0% YoY
Op. Cash Flow (TTM)
-$1M
▲ +13.0% YoY
Net Debt
-$84K
Net Cash Position
Cash & Equiv.
$84K
Continue Research
Peers
Services-Computer Processing & Data Preparation · Pick stocks to compare with AVAI
Avai Bio (AVAI) in three numbers
Questions about Avai Bio
Is Avai Bio a high-quality business?
Avai Bio scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 3 checks computed from SEC filings. Its best check is net debt at -$83586, and its weakest is return on capital at -3215.5%. The Quality tab shows every check against its target.
Does Avai Bio (AVAI) pay a dividend?
No. Avai Bio (AVAI) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 13 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in AVAI's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AVAI
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.